Haleon IPO: GSK gets shareholders' nod; all you should know

Highlights While the FTSE 100 index was trading in red on 7 April, AstraZeneca shares were up after the announcement of its phase three Champion-MG trial results. According to the results, Ultomiris has exhibited long-term efficacy in adults su...

Highlights Healthcare stocks have gained a lot of investor attention during the pandemic phase. UK healthcare companies, such as AstraZeneca and GlaxoSmithKline, are adapting to the changing environment very quickly and many of them have bright...

Highlights OKYO Pharma is aiming to get its ADSs listed on Nasdaq and has submitted a registration statement with the US SEC for the same. The exclusive book-running manager for the IPO is the California-based investment banking firm ThinkEquit...

Highlights GlaxoSmithKline Plc has come one step closer to the proposed demerger of its consumer healthcare business by announcing the name of the new entity. The proposed demerger will be a milestone in the company’s history which was fi...

Highlights  London’s FTSE100 index was in a buoyant mood on 10 February after it saw third day of gains in a row. The total revenues of AstraZeneca increased by 41% to $37,417 million in 2021, and it has raised its 2022 sales forecas...

British pharmaceutical giant GlaxoSmithKline Plc (LON: GSK) is back in the news after the company reported robust results for the year 2021 before the structured disposal of its consumer healthcare division. The company reported a 9% hike in its ad...

The UK-based pharmaceutical company, GlaxoSmithKline Plc (LON: GSK), which is into research and development of medicine and consumer healthcare products, announced that one of its investment companies, ViiV Healthcare, which is jointly owned with P...

Highlights  FairCharge, a national EV-related campaign, called on the UK treasury to stop the unfair VAT policy levied on EVs when they are charged from public charging points. Public charging VAT currently stands at 20 per cent, while dom...

Pharma and biotech-focused companies have seen huge investments after the onset of the pandemic. The UK received record levels of investment into its life sciences sector in 2021, with VC (Venture Capital) and PE (Private Equity) investment into th...

Highlights The consumer health business of GSK received multiple takeover bids, including a £50 billion bid just before Christmas in 2021 by consumer-goods giant, Unilever Plc. Unilever Plc’s cash and shares offer was rejected as it...